345 related articles for article (PubMed ID: 3216495)
1. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
[No Abstract] [Full Text] [Related]
2. [Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
Yamazaki H; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Nakamura T; Ueno K; Ito Y; Imajo K; Mukaiyama T
Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1404-11. PubMed ID: 3825458
[No Abstract] [Full Text] [Related]
3. [Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
Hayashi T; Takahashi T; Mihara M; Shimizu H; Tsukuda H; Kobayashi T; Adachi M; Hinoda Y; Aoki S; Mori M; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1997 May; 24(7):889-91. PubMed ID: 9170532
[No Abstract] [Full Text] [Related]
4. [Clinical study on advanced non-Hodgkin's lymphoma with special reference to the results of chemotherapies with ACOP, ACOP-E and AclBEP regimen].
Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T; Saito Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1176-84. PubMed ID: 3430011
[No Abstract] [Full Text] [Related]
5. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
Longo DL; DeVita VT; Young RC
N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
[No Abstract] [Full Text] [Related]
6. [A comparative study of ABEP and ACOPE in the treatment of non-Hodgkin's lymphoma CS IV].
Yoshida T; Nakamura S; Ohtake S; Itoh K; Kobayashi K; Hirai J; Kanno M; Matsuda T; Naito K; Nakamura E
Rinsho Ketsueki; 1988 Sep; 29(9):1383-7. PubMed ID: 3216509
[No Abstract] [Full Text] [Related]
7. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
8. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Cuthbert RJ; Craig JI; Ludlam CA
Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
[No Abstract] [Full Text] [Related]
10. [THP-adriamycin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma].
Ishige K; Matsue K; Tsukuda K; Sakai C; Takagi T
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2037-40. PubMed ID: 1417012
[TBL] [Abstract][Full Text] [Related]
11. A clinical phase II study of ProMACE-CytaBOM.
Dahlberg S; Miller TP; Fisher RI
J Clin Oncol; 1991 May; 9(5):888. PubMed ID: 1707958
[No Abstract] [Full Text] [Related]
12. [Results of modified LSA2-L2 protocol with moderate-dose MTX therapy in children with untreated non-Hodgkin's lymphoma].
Shimamoto Y; Imai S; Endo N
Gan To Kagaku Ryoho; 1992 Mar; 19(3):395-8. PubMed ID: 1543367
[No Abstract] [Full Text] [Related]
13. [Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
Kumagai K; Takagi T; Sakai C; Wakatsuki S
Gan To Kagaku Ryoho; 1996 Mar; 23(4):499-501. PubMed ID: 8678506
[No Abstract] [Full Text] [Related]
14. [Advanced abdominal non-Hodgkin's lymphoma in the child. Features and response to treatment].
Lobo-Sanahuja F; García I; Vargas G; Barrantes J; Jiménez E; Jiménez R
Sangre (Barc); 1988 Jun; 33(3):196-201. PubMed ID: 3175816
[No Abstract] [Full Text] [Related]
15. Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
Marotta G; Bigazzi C; Bocchia M; Forconi F; Lauria F
Haematologica; 1998 Sep; 83(9):853-4. PubMed ID: 9825583
[TBL] [Abstract][Full Text] [Related]
16. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
[TBL] [Abstract][Full Text] [Related]
18. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
[TBL] [Abstract][Full Text] [Related]
19. [The use of novantrone in combination with other preparations in hematosarcoma patients].
Kruglova GV; Demina EA; Evtushenko VV
Ter Arkh; 1992; 64(7):40-3. PubMed ID: 1440366
[No Abstract] [Full Text] [Related]
20. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
